Literature DB >> 10899394

Expression of fos-related antigen-2 in rat hippocampus after middle cerebral arterial occlusion.

K R Pennypacker1, S Eidizadeh, C A Kassed, J P O'Callaghan, P R Sanberg, A E Willing.   

Abstract

AP-1 transcription factors have been shown to be induced in the brain after ischemic injury. However, their roles in neuronal survival or death have yet to be defined. Here, we report the discovery of elevated nuclear levels of fos-related antigen-2 (FRA-2) in the nuclei of hippocampal neurons seven days after middle cerebral artery occlusion (MCAO). Expression of FRA-2 and AP-1 DNA binding activity is elevated in hippocampi ipsilateral as well as contralateral to MCAO. Using Fluoro-Jade staining as a marker of neurodegeneration, FRA-2 was not found to be expressed in degenerating neurons. Thus, FRA-2 is expressed in neurons that survive ischemic insult suggesting a role for this transcription factor in neuronal adaptation to the post-injury state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899394     DOI: 10.1016/s0304-3940(00)01250-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  The transcriptional response to hypoxic insult controlled by FRA-2.

Authors:  Tanya L Butler; Keith R Pennypacker
Journal:  Gene Expr       Date:  2005

2.  Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.

Authors:  M Smith; Z Burke; A Humphries; T Wells; D Klein; D Carter; R Baler
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Restraint-induced fra-2 and c-fos expression in the rat forebrain: relationship to stress duration.

Authors:  M S Weinberg; M Girotti; R L Spencer
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

4.  Balanced Activation of Striatal Output Pathways by Faster Off-Rate PDE10A Inhibitors Elicits Not Only Antipsychotic-Like Effects But Also Procognitive Effects in Rodents.

Authors:  Akina Harada; Nidhi Kaushal; Kazunori Suzuki; Atsushi Nakatani; Konstantin Bobkov; John A Vekich; Joseph P Doyle; Haruhide Kimura
Journal:  Int J Neuropsychopharmacol       Date:  2020-02-01       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.